{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-10",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20260610",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "86227",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/761458Orig1s002ltr.pdf",
              "date": "20260611",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20251216",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "application_docs": [
            {
              "id": "84461",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/761458Orig1s000ltr.pdf",
              "date": "20251219",
              "type": "Letter"
            },
            {
              "id": "84768",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761458Orig1s000lbl.pdf",
              "date": "20260115",
              "type": "Label"
            },
            {
              "id": "84838",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2026/761458Orig1s000TOC.html",
              "date": "20260126",
              "type": "Review"
            }
          ]
        }
      ],
      "application_number": "BLA761458",
      "sponsor_name": "GLAXOSMITHKLINE LLC",
      "openfda": {
        "application_number": [
          "BLA761458"
        ],
        "brand_name": [
          "EXDENSUR"
        ],
        "generic_name": [
          "DEPEMOKIMAB"
        ],
        "manufacturer_name": [
          "GlaxoSmithKline LLC"
        ],
        "product_ndc": [
          "0173-0927"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "DEPEMOKIMAB"
        ],
        "rxcui": [
          "2729271",
          "2729278"
        ],
        "spl_id": [
          "ea9e3787-11e0-4516-b419-db3c219a057c"
        ],
        "spl_set_id": [
          "30332b20-2ac0-42ad-a775-d3ca7f5fe29f"
        ],
        "package_ndc": [
          "0173-0927-42",
          "0173-0927-61"
        ],
        "unii": [
          "D16EQP0KKH"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "EXDENSUR",
          "active_ingredients": [
            {
              "name": "DEPEMOKIMAB-ULAA",
              "strength": "100MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "INJECTION",
          "route": null,
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}